Protara Therapeutics
Quarterly Financials
| Values in thousands | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $332 |
Gross Profit | -88 | -98 | -83 | 166 |
EBITDA | -11,668 | -16,488 | -14,041 | -14,230 |
EBIT | -11,756 | -16,586 | -14,124 | -14,312 |
Net Income | -13,258 | -14,960 | -11,914 | -12,769 |
Net Change In Cash | 0 | 0 | 0 | 332 |
Free Cash Flow | -12,456 | -12,272 | -14,757 | -9,308 |
Cash | 12,551 | 31,496 | 91,461 | 162,798 |
Basic Shares | 42,272 | 42,270 | 40,707 | 26,432 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -332 | -341 | -247 | -1,167 |
EBITDA | -48,822 | -43,272 | -64,567 | -45,398 |
EBIT | -49,154 | -43,613 | -64,815 | -45,515 |
Net Income | -44,596 | -40,420 | -65,952 | -47,252 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -35,871 | -37,602 | -26,577 | -35,098 |
Cash | 162,798 | 39,586 | 24,127 | 35,724 |
Basic Shares | 20,592 | 11,331 | 11,259 | 11,232 |
Earnings Calls
| Quarter | EPS |
|---|---|
2025-09-30 | -$0.31 |
2025-06-30 | -$0.35 |
2025-03-31 | -$0.29 |
2024-12-31 | -$0.43 |
